Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718953 | SCV000722567 | likely benign | not provided | 2020-07-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001718953 | SCV002489067 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279415 | SCV002565345 | likely benign | Ehlers-Danlos syndrome | 2019-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341579 | SCV002639040 | benign | Cardiovascular phenotype | 2019-02-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001718953 | SCV004138068 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4, BP7 |